rs140079332

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_005660.3(SLC35A2):​c.958G>T​(p.Val320Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000165 in 1,209,466 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V320M) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 24)
Exomes 𝑓: 9.1e-7 ( 0 hom. 0 hem. )

Consequence

SLC35A2
NM_005660.3 missense

Scores

2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.11

Publications

0 publications found
Variant links:
Genes affected
SLC35A2 (HGNC:11022): (solute carrier family 35 member A2) This gene encodes a member of the nucleotide-sugar transporter family. The encoded protein is a multi-pass membrane protein. It transports UDP-galactose from the cytosol into Golgi vesicles, where it serves as a glycosyl donor for the generation of glycans. Mutations in this gene cause congenital disorder of glycosylation type IIm (CDG2M). Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Oct 2014]
SLC35A2 Gene-Disease associations (from GenCC):
  • SLC35A2-congenital disorder of glycosylation
    Inheritance: XL, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07769337).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC35A2NM_005660.3 linkc.958G>T p.Val320Leu missense_variant Exon 4 of 5 ENST00000247138.11 NP_005651.1 P78381-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC35A2ENST00000247138.11 linkc.958G>T p.Val320Leu missense_variant Exon 4 of 5 1 NM_005660.3 ENSP00000247138.5 P78381-1

Frequencies

GnomAD3 genomes
AF:
0.00000892
AC:
1
AN:
112084
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
9.11e-7
AC:
1
AN:
1097382
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
362762
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26396
American (AMR)
AF:
0.00
AC:
0
AN:
35143
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19375
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30191
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53998
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40494
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4128
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
841594
Other (OTH)
AF:
0.00
AC:
0
AN:
46063
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000892
AC:
1
AN:
112084
Hom.:
0
Cov.:
24
AF XY:
0.00
AC XY:
0
AN XY:
34262
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30855
American (AMR)
AF:
0.00
AC:
0
AN:
10614
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2643
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3587
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2728
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6082
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53137
Other (OTH)
AF:
0.00
AC:
0
AN:
1512
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

SLC35A2-congenital disorder of glycosylation Uncertain:1
Aug 31, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine with leucine at codon 320 of the SLC35A2 protein (p.Val320Leu). The valine residue is moderately conserved and there is a small physicochemical difference between valine and leucine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with SLC35A2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
15
DANN
Benign
0.84
DEOGEN2
Benign
0.25
T;.;.;T;.
FATHMM_MKL
Benign
0.69
D
LIST_S2
Benign
0.82
T;T;T;T;T
M_CAP
Uncertain
0.16
D
MetaRNN
Benign
0.078
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.015
N;N;.;.;.
PhyloP100
1.1
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
0.53
N;N;.;.;N
REVEL
Benign
0.047
Sift
Benign
1.0
T;T;.;.;T
Sift4G
Benign
0.79
T;T;T;T;T
Polyphen
0.0030
B;B;.;B;.
Vest4
0.20
MutPred
0.69
Loss of sheet (P = 0.1158);Loss of sheet (P = 0.1158);.;.;.;
MVP
0.15
MPC
0.88
ClinPred
0.051
T
GERP RS
3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.077
gMVP
0.78
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140079332; hg19: chrX-48762228; API